Comment
doi: 10.1056/NEJMc1708485.
Myeloproliferative Neoplasms
Affiliations
- PMID: 28854087
- DOI: 10.1056/NEJMc1708485
Item in Clipboard
Comment
Myeloproliferative Neoplasms
N Engl J Med.
.
No abstract available
Comment in
-
Myeloproliferative Neoplasms.N Engl J Med. 2017 Aug 31;377(9):895-6. doi: 10.1056/NEJMc1708485. N Engl J Med. 2017. PMID: 28854086 No abstract available.
Comment on
-
Myeloproliferative Neoplasms.N Engl J Med. 2017 Jun 1;376(22):2168-2181. doi: 10.1056/NEJMra1406186. N Engl J Med. 2017. PMID: 28564565 Review. No abstract available.
Similar articles
-
Association of JAK2 mutation status and cytogenetic abnormalities at diagnosis in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms.Am J Clin Pathol. 2012 Apr;137(4):677-8. doi: 10.1309/AJCP74TSVUHHAJFX. Am J Clin Pathol. 2012. PMID: 22431549 No abstract available.
-
Double-mutant myeloproliferative neoplasms.Med Oncol. 2018 Aug 29;35(10):137. doi: 10.1007/s12032-018-1200-x. Med Oncol. 2018. PMID: 30159793 No abstract available.
-
The JAK2 V617F mutation in pediatric myeloproliferative neoplasms: how and when?Pediatr Hematol Oncol. 2014 Mar;31(2):138-9. doi: 10.3109/08880018.2013.869288. Epub 2014 Jan 2. Pediatr Hematol Oncol. 2014. PMID: 24383477 No abstract available.
-
[Myeloproliferative diseases caused by Jak2 gene mutation].Rinsho Ketsueki. 2007 Mar;48(3):183-7. Rinsho Ketsueki. 2007. PMID: 17441474 Review. Japanese. No abstract available.
-
[JAK2 mutation in myeloproliferative disorders].Rinsho Ketsueki. 2006 Aug;47(8):693-700. Rinsho Ketsueki. 2006. PMID: 16986707 Review. Japanese. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
